Examination of the Pancreas in New-onset Diabetes


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 10-006868
    NCT ID: NCT02001337
    Sponsor Protocol Number: 10-006868

About this study

The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Study closed to enrollment

Patient Characteristics:

  • Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values
    • HbA1C ≥ 6.5%
  • No acute illness or steroid therapy
  • No prior pancreas surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Suresh Chari, M.D.

Closed for enrollment

Contact information:

Jennifer Brooks




Mayo Clinic Footer